Bloomberg Business Week | Can You Trust Generics?

In the September 2019 print issue of Bloomberg Business Week featured a cover story titled, "Can You Trust generics?" In this 8-page spread covers how 90% of the pharmaceuticals sold in the US are generics and the recent discovery of the chemical N-Nitrosodimethylamine, or NDMA, in batches of commonly used ones. The article goes further to leave its readers with the important question, "Valsartan is just the one we caught. Who knows how many more are out there?"

View a digital version of this article via Susan Berfield's website here.

This article was then adapted to be released online on Bloomberg titled, "Carcinogens Have Infiltrated the Generic Drug Supply in the U.S.."

View the full online article via Bloomberg here.

Bloomberg Business Week | Can You Trust Generics?

April 6, 2022

In the September 2019 print issue of Bloomberg Business Week featured a cover story titled, "Can You Trust generics?" In this 8-page spread covers how 90% of the pharmaceuticals sold in the US are generics and the recent discovery of the chemical N-Nitrosodimethylamine, or NDMA, in batches of commonly used ones. The article goes further to leave its readers with the important question, "Valsartan is just the one we caught. Who knows how many more are out there?"

View a digital version of this article via Susan Berfield's website here.

This article was then adapted to be released online on Bloomberg titled, "Carcinogens Have Infiltrated the Generic Drug Supply in the U.S.."

View the full online article via Bloomberg here.

Bloomberg Business Week | Can You Trust Generics?

In the September 2019 print issue of Bloomberg Business Week featured a cover story titled, "Can You Trust generics?" In this 8-page spread covers how 90% of the pharmaceuticals sold in the US are generics and the recent discovery of the chemical N-Nitrosodimethylamine, or NDMA, in batches of commonly used ones. The article goes further to leave its readers with the important question, "Valsartan is just the one we caught. Who knows how many more are out there?"

View a digital version of this article via Susan Berfield's website here.

This article was then adapted to be released online on Bloomberg titled, "Carcinogens Have Infiltrated the Generic Drug Supply in the U.S.."

View the full online article via Bloomberg here.

In the September 2019 print issue of Bloomberg Business Week featured a cover story titled, "Can You Trust generics?" In this 8-page spread covers how 90% of the pharmaceuticals sold in the US are generics and the recent discovery of the chemical N-Nitrosodimethylamine, or NDMA, in batches of commonly used ones. The article goes further to leave its readers with the important question, "Valsartan is just the one we caught. Who knows how many more are out there?"

View a digital version of this article via Susan Berfield's website here.

This article was then adapted to be released online on Bloomberg titled, "Carcinogens Have Infiltrated the Generic Drug Supply in the U.S.."

View the full online article via Bloomberg here.

SIGN UP FOR THE VALISURE NEWSLETTER 

Sign up to stay updated with Valisure announcements, relevant industry news, company updates, and more. 

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.